Registro completo |
Provedor de dados: |
BJMBR
|
País: |
Brazil
|
Título: |
Preparation and cytotoxicity of cisplatin-containing liposomes
|
Autores: |
Carvalho Júnior,A.D.
Vieira,F.P.
De Melo,V.J.
Lopes,M.T.P.
Silveira,J.N.
Ramaldes,G.A.
Garnier-Suillerot,A.
Pereira-Maia,E.C.
De Oliveira,M.C.
|
Data: |
2007-08-01
|
Ano: |
2007
|
Palavras-chave: |
Cisplatin
Liposomes
Encapsulation
Cytotoxicity
|
Resumo: |
We encapsulated cisplatin into stealth pH-sensitive liposomes and studied their stability, cytotoxicity and accumulation in a human small-cell lung carcinoma cell line (GLC4) and its resistant subline (GLC4/CDDP). Since reduced cellular drug accumulation has been shown to be the main mechanism responsible for resistance in the GLC4/CDDP subline, we evaluated the ability of this new delivery system to improve cellular uptake. The liposomes were composed of dioleoylphosphatidylethanolamine (DOPE), cholesteryl hemisuccinate (CHEMS), and distearoylphosphatidylethanolamine-polyethyleneglycol 2000 (DSPE-PEG2000) and were characterized by determining the encapsulation percentage as a function of lipid concentration. Among the different formulations, DOPE/CHEMS/DSPE-PEG liposomes (lipid concentration equal to 40 mM) encapsulated cisplatin more efficiently than other concentrations of liposomes (about 20.0%, mean diameter of 174 nm). These liposomes presented good stability in mouse plasma which was obtained using a 0.24-M EDTA solution (70% cisplatin was retained inside the liposomes after 30 min of incubation). Concerning cytotoxic effects, they are more effective (1.34-fold) than free cisplatin for growth inhibition of the human lung cancer cell line A549. The study of cytotoxicity to GLC4 and GLC4/CDDP cell lines showed similar IC50 values (approximately 1.4 µM), i.e., cisplatin-resistant cells were sensitive to this cisplatin formulation. Platinum accumulation in both sensitive and resistant cell lines followed the same pattern, i.e., approximately the same intracellular platinum concentration (4.0 x 10-17 mol/cell) yielded the same cytotoxic effect. These results indicate that long-circulating pH-sensitive liposomes, also termed as stealth pH-sensitive liposomes, may present a promising delivery system for cisplatin-based cancer treatment. This liposome system proved to be able to circumvent the cisplatin resistance, whereas it was not observed when using non-long-circulating liposomes composed of phosphatidylcholine, phosphatidylserine, and cholesterol.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000800017
|
Editor: |
Associação Brasileira de Divulgação Científica
|
Relação: |
10.1590/S0100-879X2006005000125
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Medical and Biological Research v.40 n.8 2007
|
Direitos: |
info:eu-repo/semantics/openAccess
|
|